Regional Banks’ Profitability Problem

As earnings season unfolds, many market participants are watching regional banks closely for signs of stress. Although the public and private sectors worked together to stem the crisis earlier this year, many of the underlying conditions that contributed to it still exist. As a result, fears are growing that more weakness is ahead for the industry. 😨

Regions Financial, Berkshire Hills Bancorp, and Huntington Bancshares had similar things to say when reporting results today. But we’ll focus on Regions because it fell the most.

The Birmingham, Alabama-based lender saw a 6.5% QoQ decline in net interest income, causing it to miss revenue expectations. It expects another 5% QoQ decline in the fourth quarter. Deposits appear to be stabilizing at $126.2 billion, down marginally from the second quarter’s $127 billion. 🔻

However, the bank is having to pay up to retain its deposits and attract new ones in a highly competitive environment. That’s weighing on its net interest income, its primary profit driver. And investors remain uncertain about these banks’ unrealized losses and potential regulatory changes resulting from this spring’s crisis. 💸

Regions Financial’s President and CEO John Turner tried to reassure the market on the banks’ position, saying, “Our protective hedging strategies position us for success in any rate environment and support our commitment to generating consistent, sustainable long-term performance…” and “While the industry continues to face economic and regulatory uncertainty, we are confident in our ability to adapt to the changing landscape while continuing to deliver top-quartile returns through the cycle.”

With that said, confidence is clearly waning among investors. $RF shares fell 12% today, and all of these stocks’ shares are approaching their spring lows as the industry ETF $KRE breaks down again. As always, we’ll have to wait and see how others fared as earnings come out. But for now, fears are they will be in a similar spot, resulting in more pressure on the industry. 😟

More in   Earnings

View All

Another Day, Another Chip Rally

It’s another day, which means investors and traders were buying anything in the semiconductor space that isn’t tied down. Let’s see what you missed. 👇

First up, chip-equipment company Applied Materials soared to new all-time highs after citing “artificial intelligence” momentum during its earnings call. Adjusted earnings per share and revenues both topped expectations, while its current-quarter expectations also beat estimates. 🏭

Read It

Buyers Move Beyond Tech

Animal spirits have been a big theme of this newsletter since October, and boy, are things getting wild. While the mainstream media continues focusing on tech giants like Nvidia, investors and traders are searching far and wide for new opportunities to squeeze the shorts and make a killing. 🕵️‍♂️

Today’s surefire sign of this speculative fervor building in the market is everyone’s favorite non-meat meat stock, Beyond Meat. 🫨

Read It

Target Hits Its Mark With Membership Push

Once companies discovered that membership and loyalty programs drove additional customer visits and spending, there became apps for everything. Trust me, I’ve got the McDonald’s app on my phone because I get free fries or something with my occasional purchase… 📱

Nonetheless, this shit clearly works, and everyone wants a part of it. Given Target’s recent struggle, it’s not surprising that it’s jumping on the bandwagon as part of its turnaround strategy. 

Read It

Lyft’s IR Department Just Whiffed

Investor relations departments are the silent heroes of a public company, receiving little recognition for the critical role they play. When they do receive a lot of attention, it’s generally not for good reason. That’s unfortunately what Lyft’s team is finding out today. 😵‍💫

After the bell, ridesharing company Lyft reported fourth-quarter results that were good, not great. But the stock immediately shot up and notched as high as a 60% gain before anyone realized what happened. Did the company just invent a cure for rare diseases? Are they pivoting to crypto or semiconductors? What was the cause of this?

Read It